Therapeutic Efficacy of Isoflavone - Forte against HIV: A Case Series

A. Tavartkiladze, G. Simonia, N. Okrostsvaridze, G.Tavartkiladze

Abstract: Background: Despite the effectiveness of current HIV therapies, such as highly active antiretroviral therapy (HAART), eradicating latent viral reservoirs remains a challenge. Isoflavone-Forte, a formulation rich in viral replication blockers, anti-inflammatory, and anticancer agents, may offer a solution. This study investigates its efficacy in HIV-positive patients with a history of tuberculosis. Methods: Five patients were treated with Isoflavone-Forte derived from Polygonum cuspidatum resin, extracted via a chromatographic separation method. Results: All patients experienced significant reductions in viral load and improvements in immune parameters. No side effects were reported during or after treatment. Conclusions: These results suggest that Isoflavone-Forte effectively mitigates HIV infection, improving viral load and immune parameters, with no observed side effects. While these outcomes show promise for Isoflavone-Forte as a beneficial therapeutic strategy for HIV, further studies are necessary for validation.luable insights for improving individualized care in NSCLC.

Keywords: Isoflavone-Forte, Polygonum cuspidatum,HIV treatment, SARS-CoV-2, patients with HIV and tuberculosis, Disease stabilization